# Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma

> **NCT00280683** · PHASE2 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 20 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** L-arginine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00280683
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00280683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00280683, "Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00280683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*